Latest Vesalic News & Updates

See the latest news and media coverage for Vesalic. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Vesalic

Biotech developing ALS therapies and diagnostics

vesalic.com
Headquarters
London, United Kingdom
Founded year
2023
Company type
Private company
Number of employees
5–10

Latest news about Vesalic

Company announcements

  • Vesalic

    Vesalic advances ALS therapeutics and diagnostics

    They leverage a systemic process discovery and blood-based signature. Advances may revolutionize treatment and impact other neurodegenerative diseases.

  • Vesalic

    Vesalic advances ALS platform at TRICALS Masterclass

    Valeria Ricotti and Thomas Voit attended the event in Amsterdam, discussing trial design, real-world data, and patient-centered approaches. Vesalic develops biomarkers and therapeutics targeting ALS extracellular vesicles.

  • Vesalic

    Vesalic advances new therapeutic target

    It uses novel biomarker-based technology based on a previously unrecognized disease signature. FirstWord Pharma highlights the recent launch.

  • Vesalic

    Vesalic Limited emerges from stealth announcing ALS discovery

    The company reveals a systemic metabolic dysfunction driving motor neuron diseases and develops therapeutic and biomarker solutions for ALS and other NDDs.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Vesalic

Track Vesalic and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.